Register for streaming realtime charts, analysis tools, and prices.
Antares Pharma (ATRS) is being set up to run to at least $3.85, Thesis follows below;
The chart above shows “quiet” accumulation. The purple line is the accumulation, notice for the first time, the accumulation points up, MACD and RSI trending up, but price action is flat. Now go to http://regsho.finra.org/regsho-Index.html and look up ATRS. You will see there how the short interest on a daily basis is very high. This is clearly being done by warrant holders looking to suppress price, while quietly accumulating long, using share churning techniques, but not to generate commissions, but to control the price, hoping also to wear the patience out of retail investors, so that they sell –this is a frequent tactic done by warrant holders who are preparing to run the price so they can execute their warrants at the exercise price and sell into the run.
Warrant expirations are coming soon in Antares, with a few million at $3.85. Short from a higher price with more shares, and on the way down, short a little less, until their average short price is in line to allow them to cover for a small profit or even. Ignorant retail shorts then get caught in a short squeeze that the warrant holders cause and cover. Momentum players see the run and pile on. The stock price then goes over the reversible price, allowing warrants to convert. the buying causing even more buying, until it hits a top, where the warrant holders sell for big profit. They make money both long and short.
